The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Wed., Jun. 29, 10:07 AM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #94. Cesca Therapeutics Inc. (f/n/a ThermoGenesis Corp.) TotipotentRX Corporation

Acquirer: Cesca Therapeutics Inc. (f/n/a ThermoGenesis Corp.) (KOOL)
Acquiree: TotipotentRX Corporation
Details: Cesca Therapeutics Inc. (f/n/a ThermoGenesis Corp.) ("Company") (Nasdaq:KOOL) today announced that it consummated the merger with TotipotentRX Corporation ("TotipotentRX") for approximately 12,490,800 shares of the Company's common stock, as contemplated by the previously announced Agreement and Plan of Reorganization (the "Merger Agreement").

Cesca Therapeutics develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. Co. develops and supplies automation technologies for the isolation, purification and storage of stem cells for the cord blood banking industry. Through its ThermoGenesis Corp. subsidiary, Co. provides the AutoXpress® and BioArchive® platforms for automated clinical bio-banking, PXP® platform for point-of-care cell-based therapies and CAR-TXpress™ platform under development for bio-manufacturing for immuno-oncology applications. Co. is also developing autologous cell-based therapies that address needs in the vascular and orthopedic markets.

Open the KOOL Page at The Online Investor »

Company Name: 
ThermoGenesis Holdings Inc
Medical Instruments & Supplies

Open the KOOL Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree KOOL Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 94 of 100 Page |

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.